Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Microneedling plus topical bleomycin versus cryotherapy for refractory hand and foot warts
IRCT20221109056452N1Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of bleomycin in Refractory hand wart (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoints: Physician-assessed treatment effectiveness, Patient-assessed treatment effectiveness and 1 more. Started Mar 2023; status: completed.
02
Drugs
bleomycin
03
Conditions
Refractory hand wart
Beyond the preview
Go deeper on IRCT20221109056452N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221109056452N1.